News by community

04.09.2015 ADC Therapeutics lève $ 80 millions

ADC Therapeutics, an oncology drug discovery and development company headquartered in Biopôle (technological parc – Epalinges near Lausanne), today announced that it has raised $80 million through a private placement of equity. New investors include leading European and US-based investors alongside founding investor Auven Therapeutics and participation from AstraZeneca.

> Website

back